✦ LIBER ✦

Impressing phase II results with bortezomib combo for MM

Book ID: 120847320
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2007
Weight: 121 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200715950-00024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A349 Phase I/II Trial of Perifosine + Bo

A349 Phase I/II Trial of Perifosine + Bortezomib in Rel/Ref MM Patients Previously Treated with Bortezomib

✍ Richardson, PG; Wolf, J; Jakubowiak, A; Zonder, J; Lonial, S; Irwin, D; Densmore 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 86 KB

Therapy with bortezomib plus lenalidomid

Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: final results of a phase II trial (CALGB 50501)

✍ Morrison, Vicki A.; Jung, Sin-Ho; Johnson, Jeffrey; LaCasce, Ann; Blum, Kristie 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 620 KB

Bortezomib salvage followed by a Phase I

Bortezomib salvage followed by a Phase I/II study of bortezomib plus high-dose melphalan and tandem autologous transplantation for patients with primary resistant myeloma

✍ Taiga Nishihori; Todd J. Alekshun; Kenneth Shain; Daniel M. Sullivan; Rachid Baz 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

Sequential vincristine, adriamycin, dexa

Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial

✍ Hye Jin Kim; Sung-Soo Yoon; Dong Soon Lee; Sang Kyun Sohn; Hyeon Seok Eom; Jung 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 184 KB

Phase II study of single-agent bortezomi

Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia

✍ Stefan Faderl; Kanti Rai; John Gribben; John C. Byrd; Ian W. Flinn; Susan O'Brie 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

Phase I/II trial assessing bendamustine

Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma

✍ Berenson, James R.; Yellin, Ori; Bessudo, Alberto; Boccia, Ralph V.; Noga, Steph 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB